There are many complications that can harm a newborn during delivery. One of the worst is hypoxia-ischemia, a serious complication that can restrict blood flow, depriving the brain of oxygen. The results can range from mild to serious, from minor learning disabilities to the inability of motor skills, and loss of sight.
Hypoxia-ischemia can result in lifelong suffering, but a promising new treatment may help to reduce or prevent this brain injury. A new study was performed on a newborn experimental model brain. The study used standard cooling therapy, or therapeutic hypothermia, combined with a selective Src kinase inhibitor, PP2, which blocks a regulatory enzyme of apoptosis, also known as cell death. Hypoxia-ischemia is known to intensify cell death. An Src kinase inhibitor has been approved by the Food and Drug Administration as an oncology treatment.
Currently, only therapeutic hypothermia is used to treat hypoxia-ischemia. This combined treatment approach may help to further lessen damage to the newborn brain. Hypoxia-ischemia can occur before or during delivery because of maternal/placental problems, such as placental abruption or cord prolapse. It can also be caused by asphyxia caused by labor difficulties, infection, fetal-maternal bleeding, or twin-to-twin transfusion.
If your child has suffered a birth injury that you believe was due to the negligence of a medical professional, the New Jersey birth injury lawyers at Eichen Crutchlow Zaslow & McElroy, LLP can help. Please call 732-777-0100, or contact us online. We will provide the guidance you need to recover compensation for your suffering. Our offices are conveniently located in Edison, Red Bank, and Toms River, and we represent clients throughout the state of New Jersey.